Vivo Capital, based in California, backs healthtech and life sciences companies at Series A and B, mostly following other investors, with $6.1B in active AUM.
19 people on the investing team, 8 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Vivo Capital reports entry at series a, series b.
Vivo Capital has not reported a check size.
Vivo Capital mostly follows other investors.
Chen Meng (Managing Director), Frank Kung (Managing Partner), Gaurav Aggarwal (Managing Partner), Hao Dong (Managing Director), Michael Chang (Managing Partner), Shan Fu (Managing Partner).
No recent activity since September 2026.
Work at Vivo Capital? Claim or correct this profile.